Health ❯Healthcare

Regulations

FDA Drug Approval Drug Safety Medical Ethics FDA Approval Hospital Compliance EU Regulations Government Agencies FDA Oversight Food Safety

FDA Targets Unapproved Kratom-Derived Opioid Compound in Seven Warning Letters

Companies have 15 business days to prove they have halted the illicit marketing of 7-hydroxymitragynine products.

French Blood Service Urges Donors to Boost Summer Reserves

AHPRA Introduces Safety and Advertising Guidelines for Cosmetic Injectables

FDA Approves First At-Home Cervical Cancer Test

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves

Spain Orders Withdrawal of Injected Cosmetic Products Containing Hyaluronidase

FDA Audit Triggers Nationwide Recall of Over 75,000 Eye Care Products

Nationwide Recall of Eye Care Products Over Sterility Concerns

Novo Nordisk Revises 2025 Outlook as FDA Crackdown and Competition Reshape Wegovy Market

EU Commission Approves First Alzheimer’s Therapy Targeting Disease Progression

Pune Hospital Found Guilty of Violating Emergency Care Norms After Pregnant Woman’s Death

Sydney Beauty Clinic Shut Down Over Unsafe Practices and Use of Veterinary Equipment

Eli Lilly Lowers 2024 Revenue Forecast Due to Slower Weight-Loss Drug Growth

Warnings Issued Over Unsafe Online Sales of Weight-Loss Injections

EU to Ban Amalgam Dental Fillings Starting in 2025

Growing Demand for Weight-Loss Drugs in the UK Raises Safety and Accessibility Concerns

France Restricts Sale of Eight Popular Cold Medications Over Safety Concerns

Nova Scotia Attracts Over 100 Foreign-Trained Pharmacists with Streamlined Licensing Program

FDA Proposes Removal of Ineffective Oral Phenylephrine from Cold Medicines

FDA Recalls Duloxetine Over Cancer-Causing Chemical Concerns